Galaxy Surfactants Ltd Grants Stock Options Under Performance Stock Option Plan 2025
Galaxy Surfactants Limited has approved the grant of stock options to eligible employees under the GALAXY SURFACTANTS LIMITED - PERFORMANCE STOCK OPTION PLAN 2025 (PSOP 2025). The decision was made by the Nomination and Remuneration Committee of the company.The plan introduces a performance-based incentive structure for employees, subject to specific vesting conditions outlined in the PSOP 2025 Scheme and grant letters.
According to the details provided regarding the options granted:
| Particulars | Details |
|---|---|
| Options Granted | 8400 options |
| Share Face Value | Rs. 10/- each |
| Exercise Price | Rs. 10/- per option |
| Vesting Schedule | After the Annual General Meeting for the Financial Year 2028-29 |
| Maximum Entitlement | Up to 157,383 options |
The stock options are designed as a Share Based Employee Benefit (SBEB). The terms of the plan stipulate that vesting is contingent upon meeting performance criteria set by the Nomination and Remuneration Committee and maintaining continued employment with the company.
Key operational details of the grant include:
- Options Covered: 8400 equity shares, each having a face value of Rs. 10/-.
- Exercise Window: Vested options must be exercised within four years from the date of vesting.
- Current Status: The number of options granted is 8400, while zero options have been exercised and no money has been realized from option exercise as of this report.
The plan outlines that employees granted these options are entitled to a maximum of 157,383 options, with the final vesting being tied to the achievement of defined performance metrics within the PSOP 2025 framework.
GALAXYSURF Stock Price Movement
As of 11:24 AM, shares of Galaxy Surfactants Limited are shedding value in live trading, slipping 0.91% and currently standing at ₹1931.90. The stock recorded a volume of 1,755 shares during this trading period.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.